Download derrick scott robertson, md - University of South Florida

DERRICK SCOTT ROBERTSON, MD
Curriculum Vitae
October 2016
Mailing Address:
University of South Florida
Morsani College of Medicine
Department of Neurology
12901 Bruce B. Downs Blvd. MDC 55
Tampa, Florida 33612
Practice Address:
Carol and Frank Morsani Center for Advanced Healthcare
University of South Florida
13330 USF Laurel Drive
Tampa, Florida 33612
Contact Information:
[email protected]
Telephone:
813 974-3541
Fax Number: 813 905-9838
Education:
University of South Florida,
B.S. Interdisciplinary Natural Sciences (Cum Laude)
Tampa, Florida
1999 – 2003
University of South Florida, College of Medicine
Doctor of Medicine
Tampa, Florida
2004 – 2008
Medicine Internship
University of South Florida, College of Medicine
Tampa, Florida
2008 – 2009
Neurology Residency
Chief Resident
University of South Florida, College of Medicine
Tampa, Florida
2009 – 2012
2011 – 2012
Multiple Sclerosis Fellowship
University of South Florida, College of Medicine
Tampa, Florida
2012
Professional Experience
Assistant Professor, Department of Neurology
University of South Florida, College of Medicine
2012-Present
Director, Multiple Sclerosis Division
Department of Neurology
University of South Florida, College of Medicine
2012-Present
Program Director, Multiple Sclerosis Fellowship
Department of Neurology
University of South Florida, College of Medicine
2012-Present
Associate Program Director, Neurology Residency
Department of Neurology
University of South Florida, College of Medicine
2012-Present
Licensures
State of Florida, Medical
#ME113374
Certifications
Board Certified in Neurology,
American Board of Psychiatry and Neurology
2012-Present
Leadership Positions:
Elected Director, Board of Directors
University of South Florida Physicians Group
University of South Florida, College of Medicine
Tampa, Florida
2015 – Present
Executive Management Committee on Research
University of South Florida, College of Medicine
Tampa, Florida
2015 – Present
Program Evaluation Committee
2014 – Present
Neurology Residency Program, Department of Neurology
University of South Florida, College of Medicine
Tampa, Florida
Resident Clinical Competency Committee
2014 – Present
Neurology Residency Program, Department of Neurology
University of South Florida, College of Medicine
Tampa, Florida
Vice-Chief
Tampa General Hospital, Department of Neurology
Tampa, Florida
2014 –2016
Continuing Professional Development Committee
University of South Florida, College of Medicine
Tampa, Florida
2013 – Present
Clinical Advisory Committee
National Multiple Sclerosis Society
Mid-Florida Chapter
2013 – Present
MS Step-Up Leadership Steering Committee
National Multiple Sclerosis Society
Mid-Florida Chapter
2013 – Present
Graduate Medical Education Committee,
University of South Florida,
Tampa, Florida
2011 – Present
Chief Resident, Neurology Residency,
University of South Florida,
Tampa, Florida
2011 – 2012
Awards
Resident of the Year, University of South Florida
Tampa, Florida
2012
Resident Scholarship,
Foundation of the Consortium of Multiple Sclerosis
Centers Annual Meeting,
San Diego, CA
2012
Resident Scholarship,
American Academy of Neurology Annual Meeting,
New Orleans, LA
2012
Resident Scholarship,
Fundamentals of Pain Management:
2011
A Primer for Residents and Fellows Course,
Annual American Pain Society Scientific Meeting,
Austin, Texas
Resident Travel Award,
Florida Society of Neurology Annual Meeting,
Orlando, Florida
2010 – 2011
Teaching courses:
MDT 8800 Neuroimmunology Component in Neurological Diseases
MEL 8677 Outpatient Neurology
MEL 8690 Research in Neurology
GMS 6708 Neuroimmunology
PHA 6783 Pharmacotherapeutics II
Professional Society Memberships:
American Neurological Association
American Academy of Neurology
Florida Society of Neurology
American Pain Society
Florida Medical Association
2013 – Present
2009 – Present
2009 – Present
2011 – 2012
2004 – 2013
Publications, Peer-reviewed
Gangadhara S, Gangadhara S, Gandhy C, Robertson D. Rhabdomyolysis and
autoimmune variant Stiff-Person syndrome. Clin Pract. October 2016. Submitted.
Miller W, Konstas D, Gandhy C, Robertson D. Diagnosis of an acute, late-onset
parenchymal Neuro-Behcet’s disease without systemic manifestations. Case Rep Neurol
Med 2016;2016:5720319.
Robertson D, Moreo N. Disease-Modifying Therapies in Multiple Sclerosis: Overview and
Treatment Considerations. Fed Pract 2016 June;33(06):28-33.
Heekin R, Gandhy C, Robertson D. Seronegative Neuromyelitis Optica Spectrum
Disorder following Exposure to Hepatitis B Vaccination. Case Rep Neurol 2015;7:78-83.
Benbadis S, Sanchez-Ramos, Bozorg A, Giarratano M, Kalidas K, Katzin L, Robertson D,
Vu T, Zesiewicz T. Medical Marijuana in Neurology. Expert Rev Neurother. 2014
Dec;14(12):1453-65.
Selected Abstract Presentations:
Moreo N, Deng D, Lyman M, Soares R, Gandhy C, Robertson D. Assessing the Incidence
of Lymphopenia with the Use of Dimethyl Fumarate in Multiple Sclerosis. Poster
presentation at the Consortium of Multiple Sclerosis Centers Annual Meeting, National
Harbor, MD, 2016.
Moreo N, Deng D, Lyman M, Soares R, Gandhy C, Robertson D. Assessing the Incidence
of Elevation in Eosinophils with the Use of Dimethyl Fumarate in Multiple Sclerosis.
Poster presentation at the Consortium of Multiple Sclerosis Centers Annual Meeting,
National Harbor, MD, 2016.
Tillman E, Luther J, Casady L, Robertson D, Stephenson J. Free from Falls Program at the
University of South Florida. Poster presentation at the Consortium of Multiple Sclerosis
Centers Annual Meeting, National Harbor, MD, 2016.
Dixon C, Aungst A, Calma A, Gandhy C, Robertson D. Rapid Elimination Procedure of
Teriflunomide with Colestipol Hydrochloride. Poster presentation at the American
Neurological Association Annual Meeting, Indianapolis, IN, 2015.
Patel, P, Ganghadhara, S, Robertson D. Paroxsymal Nonkinesiogenic Dyskinesia as a
Presenting Symptom of Multiple Sclerosis: Case Report. Poster presentation at the
Florida Society of Neurology Annual Meeting, Orlando, Florida, 2014
Sista, R, Stephens, H, Robertson D. Refractory Simple Partial Seizures in a Patient with
Relapsing-remitting Multiple Sclerosis: Case Report. Poster presentation at the Florida
Society of Neurology Annual Meeting, Orlando, Florida, 2014
Sista, R, Stephens, H, Robertson D. Copper Deficiency Myeloneuropathy Misdiagnosed
as Vitamin B12 Deficiency: Case Report. Poster presentation at the Florida Society of
Neurology Annual Meeting, Orlando, Florida, 2014
Lwin W, Robertson D, Standley K. Isolated Cognitive Disturbance as an Indicator of
Acute Relapse in Multiple Sclerosis. Poster presentation at the Florida Society of
Neurology Annual Meeting, Orlando, Florida, 2013
Masi S, Robertson D, Butler M, Casady L, Seevers A. The effect of natalizumab on Sexual
Dysfunction in Multiple Sclerosis. Poster presentation as works-in-progress at The 23rd
Annual USF Health Research Day, Tampa, Florida, 2013
Robertson D, Casady L, Aungst A. Measuring Adherence to Tecfidera in Multiple
Sclerosis Patients. Poster presentation as works-in-progress at The Consortium of
Multiple Sclerosis Centers, Orlando, Florida, 2013
Robertson D, Muntean E. Balό’s Concentric Sclerosis Presenting as a Ring-enhancing
Lesion in a HIV-infected Patient. Case Report. Poster Presentation at the American
Society of Neuroimaging Annual Meeting, Miami, Florida, 2012
Robertson D, Bozorg A. Can multiple drug allergies predict the final diagnosis in patients
undergoing video-EEG monitoring? Poster Presentation at the American Epilepsy Society
Annual Meeting, San Antonio, Texas, 2010
Robertson D, Muntean E, Tsakadze N. Isolated Sphenoid Sinus Aspergillosis Presenting
as Cavernous Sinus Syndrome. Case Report. Poster Presentation at the Florida Society of
Neurology Annual Meeting, Orlando, Florida, 2009
Presentations/Invited Lectures:
Differential Diagnosis of Multiple Sclerosis and Diagnostic Challenges. Grand Rounds,
University of South Florida, Department of Neurology. Role: Invited Lecturer. October
2016.
5th Annual Khan GME Today Advanced Practice Seminar in Multiple Sclerosis. CME
Program, PRIME Education, Inc. Role: Faculty. Tampa, Florida. October 2016.
9th Annual Chair Summit. CME Program, CME Outfitters, LLC. Role: Lecturer. Miami,
Florida. September 2016.
Differential Diagnosis of Multiple Sclerosis and Diagnostic Challenges. Grand Rounds,
University of South Alabama, Department of Neurology. Role: Invited Lecturer. Mobile,
Alabama. September 2016.
3D MS THRIVE Initiative: Clinical Management and Patient Outcomes in Multiple
Sclerosis. CME Program, Med Learning Group. Role: Lecturer. Melbourne, Florida.
August 2016.
Novel Insights on the Interplay of B cells and T cells in Therapeutic Management of
Multiple Sclerosis. CME Program, PRIME Education, Inc. Role: Lecturer. Tampa, Florida.
June 2016.
Year in Review: Advances in the Treatment of Multiple Sclerosis. CME Program, PRIME
Education, Inc. Role: Lecturer. Tampa, Florida. February 2016.
Cognitive Errors in Medical Decision Making. Grand Rounds, University of South Florida,
Department of Neurology. Role: Invited Lecturer. December 2015.
Year in Review: Advances in the Treatment of Multiple Sclerosis. CME Program, PRIME
Education, Inc. Role: Lecturer. Tampa, Florida. November 2015.
6th Annual Updates from ECTRIMS: Highlights in Research and Treatment of Multiple
Sclerosis. CME Program, PRIME Education, Inc. Role: Lecturer. Tampa, Florida. October
2014.
MacIver S, Robertson D. “Chronic Relapsing Inflammatory Optic Neuropathy (CRION):
Case Report and Current Treatments”. Platform Presentation at the Florida Society of
Neurology Annual Meeting, Orlando, Florida, September 2014
5th Annual Updates from ECTRIMS: Highlights in Research and Treatment of Multiple
Sclerosis. CME Program, PRIME Education, Inc. Role: Lecturer. Tampa, Florida. October
2013.
Multiple Sclerosis Expert Panel: National Multiple Sclerosis Society Mid-Florida Chapter
14th Annual Day of Discovery. Orlando, Florida. December 2012.
New and Emerging Therapies in MS. Keynote Speaker: National Multiple Sclerosis
Society Mid-Florida Chapter Annual Meeting and Research Symposium. Tampa, Florida.
October, 2012.
Robertson D, Bozorg A. “Periodic Regional Epileptiform Discharges (PREDs): A Proposal
for a New Electroencephalographic Definition”. Platform Presentation at the Florida
Society of Neurology Annual Meeting, Orlando, Florida, September 2011.
Robertson D, Bozorg A. “Can multiple drug allergies predict the final diagnosis in
patients undergoing video-EEG monitoring?” Platform Presentation at the Florida
Society of Neurology Annual Meeting, Orlando, Florida, September 2010.
Research:
Multi-center, randomized, double-blinded assessment of Tecfidera® in extending the
time to a first attack in radiologically isolated syndrome
February 2016
Principal Investigator
Biogen
Status: Enrolling
An Open-label Study to Evaluate the Effectiveness and Safety of Ocrelizumab in
Patients with Relapsing Remitting Multiple Sclerosis who have had Suboptimal
Response to an Adequate Course of Disease-Modifying Treatment
January 2016
Principal Investigator
Genentech
Status: Enrolling
An Open-Label Study to Assess the Effects of BG00012 on Lymphocyte Subsets in
Subjects with Relapsing-Remitting Multiple Sclerosis
January 2016
Principal Investigator
Biogen
Status: Enrolling
A Phase 3b multicenter, randomized, parallel-group, open-label study to evaluate the
effects of ocrelizumab on immune responses in patients with relapsing forms of
multiple sclerosis
November 2015
Principal Investigator
Genentech
Status: Enrolling
A Phase 2a/2b double-blind, randomized, placebo-controlled study assessing
efficacy, safety, and dose-response of vatelizumab in patients with relapsing-remitting
multiple sclerosis (RRMS)
April 2015
Principal Investigator
Genzyme
Status: Closed
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy
and Safety of BG00012 in Delaying Disability Progression in Subjects With Secondary
Progressive Multiple Sclerosis
April 2015
Principal Investigator
Biogen
Status: Closed
OPTIMUM: Oral Ponesimod versus Teriflunomide In relapsing MUltiple sclerosis
Multicenter, randomized, double-blind, parallel-group, active-controlled, superiority
study to compare the efficacy and safety of ponesimod to teriflunomide in subjects
with relapsing multiple sclerosis
April 2015
Principal Investigator
Actelion
Status: Enrolling
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the
Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg,
Administered Twice Daily in Subjects with Multiple Sclerosis (ENHANCE)
November 2014
Principal Investigator
Biogen Idec, Inc.
Status: Closed
Rapid Elimination Procedure of Teriflunomide with Colestipol Hydrochloride
(Investigator Initiated Trial)
October 2014
Principal Investigator
Status: Enrolling
Grant Funding provided by Genzyme
A multicenter, retrospective, observational study evaluating real-world clinical
outcomes in relapsing-remitting multiple sclerosis patients who transition from
Tysabri®(natalizumab) to Tecfidera® (dimethyl fumarate)
September 201
Principal Investigator
Biogen
Status: Closed
A Multicenter, Global, Observational Study to Collect Information on Safety and to
Document the Drug Utilization of Tecfidera™ (Dimethyl Fumarate) When Used in
Routine Medical Practice in the Treatment of Multiple Sclerosis (ESTEEM)
April 2014
Principal Investigator
Biogen
Status: Enrolling
A single-center prospective measurement of adherence to treatment with Tecfidera™
in multiple sclerosis patients (Investigator Initiated Trial)
March 2014
Principal Investigator
Status: Active
Grant Funding provided by Biogen
A Placebo-controlled Randomized withdrawal evaluation of the efficacy and safety of
Baclofen ER capsules (GRS) in subjects with spasticity due to Multiple Sclerosis
August 2013
Principal Investigator
Sun Pharma
Status: Enrolling
A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical
Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (dimethyl
fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple
Sclerosis After Suboptimal Response to Glatiramer Acetate
October 2013
Principal Investigator
Biogen
Status: Closed
A multicenter, randomized, double-blind, parallel-group, placebo-controlled variable
treatment duration study evaluating the efficacy and safety of Siponimod (BAF312) in
patients with secondary progressive multiple sclerosis
May 2013
Principal Investigator
Novartis
Status: Active
A Phase I, Multi-center, Open-Label Dose Escalation Study to Evaluate the Safety,
Tolerability and Pharmacodynamic Activity of Intravenous MEDI-551 in subjects with
Multiple Sclerosis (MS)# CD-IA-MEDI-551-1102
May 2013
Principal Investigator
MedImmune
Status: Active
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in
Patients with Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (dimethyl
fumarate) delayed-release capsules
April 2013
Principal Investigator
Biogen
Status: Closed
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study
to Investigate the MRI Efficacy and Safety of Six Months’ Administration of
Ofatumumab in Subjects with Relapsing-Remitting Multiple Sclerosis
January 2012
Sub-Investigator
Glaxo Smith Kline
Status: Closed
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy
and Safety of Teriflunomide in Patients with Relapsing Multiple Sclerosis who are
Treated with Interferon-beta #EFC6058
November 2011
Sub-Investigator
Genzyme
Status: Closed
A Phase 2, Double-blind, Randomized, Placebo-controlled, Four-arm, Multicenter,
Dose finding Study to Assess the Safety and Efficacy of Three Dose Levels of AVP-923
(Dextromethorphan/Quinidine) in the Treatment of Central Neuropathic Pain in
Patients with Multiple Sclerosis
November 2011
Sub-Investigator
Avanir Pharmaceuticals
Status: Closed
A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate the
Efficacy and Safety of Ocrelizumab in Comparison to Interferon Beta-1a (Rebif®) in
Patients with Relapsing Multiple Sclerosis
September 2011
Principal Investigator
F. Hoffman-La Roche Ltd/Genentech
Status: Active
A Multicenter, Randomized, Double-blinded, Placebo-Controlled Study of the Efficacy
of Natalizumab on Reducing Disability Progression in Subjects with Secondary
Progressive Multiple Sclerosis
September 2011
Principal Investigator
Biogen
Status: Active
A Multicenter, Observational, Open-Label, Single-Arm Study of Tysabri in Early
Relapsing-Remitting Multiple Sclerosis in Anti-JCV Antibody Negative Patients
September 2011
Principal Investigator
Biogen
Status: Closed
The Effect of Natalizumab on Sexual Dysfunction in Multiple Sclerosis (Investigator
Initiated Trial)
September 2010
Sub-Investigator
Status: Closed
Grant Funding provided by Biogen
A Dose-Blind, Multicenter, Extension Study to Determine the Long-Term Safety and
Efficacy of Two Doses of BG00012 Monotherapy in Subjects with Relapsing-Remitting
Multiple Sclerosis. #109MS303
May 2010
Principal Investigator
Biogen
Status: Active
An Extension Protocol For Multiple Sclerosis Patients Who Participated in GenzymeSponsored Studies of Alemtuzumab
April 2009
Principal Investigator
Genzyme
Status: Active